Related Experiment Video
Updated: Dec 16, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.8K
Quantitative patterns of motor cortex proteinopathy across ALS genotypes
Matthew Nolan1, Connor Scott1, Menuka Pallebage Gamarallage1
1Nuffield Department of Clinical Neurosciences, University of Oxford, Level 1, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Acta Neuropathologica Communications
|July 4, 2020
Summary
Amyotrophic lateral sclerosis (ALS) shows varying protein buildup in the motor cortex based on genetic cause. Sporadic ALS-TDP has more severe proteinopathy and microglial activation than C9-ALS.
Area of Science:
- Neuroscience
- Neuropathology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) is characterized by motor cortex degeneration and protein aggregate accumulation.
- The quantitative burden and pattern of motor cortex proteinopathies across different ALS genetic subtypes remain poorly understood.
Purpose of the Study:
- To investigate the relationship between ALS genotype, total proteinopathy load, and cellular vulnerability to aggregate formation in the primary motor cortex.
- To explore genotype-specific patterns of protein aggregation and glial activation in ALS.
Main Methods:
- Quantitative digital image analysis of post-mortem brain tissue from 82 ALS cases.
- Multi-level generalized linear modeling to assess genotype-specific proteinopathy burden.
Main Results:
- Sporadic ALS-TDP exhibited higher phosphorylated (p)TDP-43 burden and microglial activation in the motor cortex compared to C9-ALS.
- Oligodendroglial pTDP-43 pathology was prevalent across various ALS subtypes, including sporadic ALS, C9-ALS, and those with OPTN, HNRNPA1, or TARDBP mutations.
- ALS-FUS and ALS-SOD1 showed less cortical proteinopathy relative to spinal cord pathology compared to ALS-TDP.
- Neuronal pTDP-43 aggregates were primarily found in excitatory neurons, sparing inhibitory interneurons.
- Cortical microglia, but not astrocytes, were found to contain pTDP-43.
Conclusions:
- Findings suggest divergent, genotype-specific vulnerabilities of the ALS primary motor cortex to proteinopathies.
- These insights may inform the development of genotype-specific therapies for ALS.

